Med Life SA (RO:M) — Market Cap & Net Worth
Market Cap & Net Worth: Med Life SA (M)
Med Life SA (RO:M) has a market capitalization of $1.46 Billion (RON6.37 Billion) as of May 2, 2026. Listed on the RO stock exchange, this Romania-based company holds position #7490 globally and #10 in its home market, demonstrating a -1.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Med Life SA's stock price RON12.00 by its total outstanding shares 530815985 (530.82 Million). Analyse M cash flow metrics to see how efficiently the company converts income to cash.
Med Life SA Market Cap History: 2016 to 2026
Med Life SA's market capitalization history from 2016 to 2026. Data shows change from $3.20 Billion to $1.46 Billion (-8.16% CAGR).
Index Memberships
Med Life SA is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Bucharest Plus Index
BETPLUS
|
$56.29 Billion | 2.60% | #9 of 42 |
|
Bucharest Total Return
BETTR
|
$54.75 Billion | 2.67% | #9 of 17 |
|
Bucharest BET-XT Index
BETXT
|
$55.56 Billion | 2.63% | #9 of 28 |
Weight: Med Life SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Med Life SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Med Life SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.26x
Med Life SA's market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.67x
Med Life SA's market cap is 27.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.37 Billion | $1.08 Billion | $56.70 Million | 1.27x | 24.07x |
| 2021 | $2.91 Billion | $1.43 Billion | $102.61 Million | 2.04x | 28.39x |
| 2022 | $2.06 Billion | $1.80 Billion | $32.17 Million | 1.15x | 64.02x |
| 2023 | $485.10 Million | $2.21 Billion | $3.68 Million | 0.22x | 131.67x |
| 2024 | $706.93 Million | $2.72 Billion | $25.55 Million | 0.26x | 27.67x |
Competitor Companies of M by Market Capitalization
Companies near Med Life SA in the global market cap rankings as of May 2, 2026.
Key companies related to Med Life SA by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Med Life SA Historical Marketcap From 2016 to 2026
Between 2016 and today, Med Life SA's market cap moved from $3.20 Billion to $ 1.46 Billion, with a yearly change of -8.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RON1.46 Billion | +16.73% |
| 2025 | RON1.25 Billion | +77.24% |
| 2024 | RON706.93 Million | +45.73% |
| 2023 | RON485.10 Million | -76.45% |
| 2022 | RON2.06 Billion | -29.29% |
| 2021 | RON2.91 Billion | +113.39% |
| 2020 | RON1.37 Billion | +97.53% |
| 2019 | RON691.08 Million | +26.85% |
| 2018 | RON544.82 Million | -86.89% |
| 2017 | RON4.16 Billion | +30.05% |
| 2016 | RON3.20 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Med Life SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.46 Billion USD |
| MoneyControl | $1.46 Billion USD |
| MarketWatch | $1.46 Billion USD |
| marketcap.company | $1.46 Billion USD |
| Reuters | $1.46 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Med Life SA
Med Life S.A., a private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging investigations; day hospitalization services… Read more